Why Is the Perfusion Market Growing So Fast? 2026 Analysis

Perfusion by Application (/> Hospital, Clinic, Others), by Type (/> Medical Devices, Medicines, Medical Service), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1240 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1240 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Perfusion Market Overview

Perfusion refers to the passage of fluid through the circulatory or lymphatic system to an organ or tissue, usually to provide oxygen and nutrients; in healthcare it is the cornerstone of cardiopulmonary bypass, organ transplantation, and ex-vivo organ preservation. Against a backdrop of rising transplant lists and surgical volumes, the Perfusion market size is valued at USD 1.24 billion in 2025 and is forecast to expand at a 6.3% CAGR through 2033, underpinned by a compelling growth outlook for extracorporeal circulation and organ-care technologies. The market forecast is anchored in double-digit growth in perfusion consumables and a steady 5–6% uptick in capital systems, with industry expansion propelled by regulatory incentives for marginal-donor organ utilization and shifting preference toward portable, battery-powered perfusion platforms.

Loading chart…

Macro drivers include the global aging demographic—projected to add 420 million people ≥65 years by 2030—and a ~40% increase in solid-organ transplants over the same horizon, tightening supply-demand imbalances. Technology shifts center on normothermic and hypothermic machine perfusion displacing static cold storage, while competitive intensity rises as Medtronic, Getinge, LivaNova, Terumo, and Organ Recovery Systems widen bundled service contracts. North America retains the largest revenue share (42%) thanks to high procedural volumes and reimbursement clarity; APAC is the fastest-growing region (>8% CAGR) fueled by China’s rapid hospital build-out and India’s cost-effective organ-sharing networks.

Report Overview

Report Attribute	Details
Market size value in 2025	1.24 billion
Revenue forecast in 2033	1.86 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Getinge; Medtronic; LivaNova; Terumo Medical; Xenios; Lifeline Scientific; XVIVO Perfusion; Repligen Corporation; Spectrum Laboratories; Merck; Harvard Bioscience; Ala Science
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Accelerated transplant activity and complex cardiothoracic volumes are pushing demand for ex-vivo organ and cardiopulmonary perfusion, directly expanding the addressable Perfusion market size at an estimated 8–9 % CAGR through 2030.

Next-generation miniaturized perfusion circuits, integrated sensors and AI-driven flow optimization cut priming volume 40 % and reduce LOS, incentivizing hospitals to upgrade and lifting ASPs despite procurement budget scrutiny.

Restraints

CMS reimbursement for perfusion services remains facility-based; declining DRG weights and stagnant pump rates compress provider margins and elongate capital payback to >6 years, muting near-term unit orders.

A limited pool of board-certified clinical perfusionists—projected 7 % shortfall by 2027—forces wage inflation >5 % YoY, deterring smaller centers from running on-site perfusion programs and capping installed base growth.

Opportunities

Point-of-care cell and gene perfusion bioreactors for autologous CAR-T and HSC expansion—currently <5 % penetrated—offer a greenfield segment that could add >USD 0.4 B to the Perfusion market by 2028, commanding gross margins >65 %.

Emerging markets with <25 cardiac surgery centers per 10 M capita (India, Brazil) are adding ECMO and CABG programs under public insurance; favorable FX-linked pricing and PPP-based tenders create a cost-down volume pathway for OEMs.

Challenges

Post-pandemic titanium, electronic and polymer lead times have doubled; OEM safety stock targets rise to 6 months, locking >18 % of working capital in inventory and compressing EBIT by 100–150 bps across the growth forecast window.

Regulatory convergence on disposable sterility and biocompatibility (ISO 22509, EU MDR) raises validation costs >USD 1 M per SKU, disadvantaging mid-tier players and accelerating roll-up dynamics that could trim supplier diversity 30 % by 2026.

Market Segmentation

Loading chart…

Application-based Perfusion segmentation structures demand along clinical urgency and complexity. Cardiac surgery remains the dominant revenue anchor, driven by rising valve replacements and CABG volumes; its reliance on full cardiopulmonary bypass secures the largest share. Transplant—comprising heart, lung, and combined procedures—generates the fastest growth because expanding donor pools and normothermic technologies lengthen organ viability windows. Respiratory support applications, including extracorporeal CO₂ removal for ARDS, scale with ICU capacity; growth is cyclical, mirroring influenza and chronic lung disease prevalence. Limb salvage and complex vascular reconstructions form smaller but high-value niches where perfusion-assisted chemo-infusion or hypothermia prevents amputation. Together these subsegments map how procedural acuity translates into device utilization and pricing power across the overall Perfusion market size.

Type-based market taxonomy differentiates technologies by circuit architecture and perfusate composition. Isolated organ perfusion—subdivided into ex-vivo heart, liver, and kidney platforms—supports viability testing and functional recovery, commanding premium pricing in transplant centers. Cardio-pulmonary bypass (CPB) systems, segmented into roller and centrifugal pumps, dominate in volume; choice pivots on hemolysis profiles and cost per case. ECMO splits into veno-venous for pulmonary and veno-arterial for cardio-respiratory failure; adoption accelerates as intensive-care reimbursement improves. Cell-saving and autotransfusion units are auxiliary but essential, offsetting allogeneic blood use and lowering infection risk. Finally, hypothermic versus normothermic perfusion settings determine disposables mix and service models, underlining how technical nuances within each Type influence recurring revenue and capital budgets across the Perfusion sector.

Perfusion Segmentation Breakdown8 items

Application

/> Hospital

Clinic

Others

Type

/> Medical Devices

Medicines

Medical Service

Regional Insights

Loading chart…

North America dominates the global Perfusion market with a 38% regional forecast share, propelled by CMS reimbursement alignment, a dense network of 6,200+ transplant centers, and rapid uptake of hypothermic machine perfusion platforms; favorable demographics—rising NASH-related liver failure and 65+ cohort—cement its lead.

Asia Pacific is the fastest-growing region (CAGR 9.4%) as China’s organ donation pilot cities scale to 2,800 hospitals, Japan’s revised Organ Transplant Act incentivizes DCD grafts, and India’s PLI scheme funds domestic perfusion device manufacturing; expanding private dialysis chains and 5G-enabled logistics tighten cold-ischaemia windows, driving Perfusion market growth.

Europe (28% share) benefits from the EU Organ Transplant Directive, harmonized quality standards, and Horizon Europe €240 m investment in normothermic perfusion R&D; aging population and cross-border organ exchange programs accelerate adoption across France, Germany, and Spain.

Latin America (6%) advances through Argentina’s cadaveric donor law, Brazil’s SUS procurement modernization, and public-private partnerships importing portable perfusion pumps; cost-containment focus favors leasing models, yet limited ICU infrastructure tempers regional forecast upside.

Middle East & Africa (5%) growth hinges on Saudi-vision 2030 organ donation awareness campaigns, UAE’s Dubai Health Authority lump-sum funding, and South Africa’s academic-center hubs; high unmet need and outbound medical tourism underscore nascent but accelerating Perfusion market growth.

Key Regional Drivers5 items

North America: reimbursement, dense transplant network, aging demographics

Asia Pacific: policy reforms, local manufacturing, digital logistics

Europe: regulatory harmonization, R&D funding, cross-border exchange

Latin America: legislation, PPPs, cost-sensitive leasing

MEA: awareness campaigns, government funding, medical tourism

Competitive Landscape

The perfusion competitive landscape is moderately consolidated: a handful of global full-line suppliers—Getinge, Medtronic, LivaNova, Terumo Medical—control the majority of installed base and service revenue, while regional specialists such as Xenios, XVIVO Perfusion and Ala Science secure share through niche technology or local regulatory approvals. Competitive levers revolve around evidence-based clinical outcomes, ISO 13485 and FDA 510(k) cycle times, integrated after-sales contracts, and tender pricing flexibility rather than pure R&D spend; distributors report that procurement managers now weight total cost of ownership over upfront device price by roughly 20–30% in their scoring algorithms.

To offset margin pressure driven by commoditized tubing sets and single-use disposables, players pursue M&A for installed-base expansion, forge OEM partnerships with cell-therapy CMOs, and localize assembly to bypass import tariffs. Differentiation increasingly rests on validated software protocols for remote monitoring, modular pump designs that reduce priming volume, and long-term service agreements that guarantee uptime; however, rising compliance costs for revised EU MDR labeling and tightened biocompatibility testing continue to compress EBITDA by an estimated 2–4 percentage points across the segment.

Companies Strategy Snapshot6 items

Getinge expands through bolt-on acquisitions of regional service providers

Medtronic leverages premium pricing tied to integrated data analytics

LivaNova invests in miniaturized oxygenators for pediatric niche

Terumo Medical localizes manufacturing in India to offset freight costs

XVIVO Perfusion focuses on normothermic preservation regulatory dossiers

Repligen Corporation partners with CMOs to embed single-use perfusion kits

Market Ecosystem

The perfusion ecosystem spans from upstream bioprocess component and single-use consumable suppliers through midstream bioreactor/perfusion system integrators to downstream therapeutic developers, contract manufacturers and hospital pharmacies. Value is created by translating sterile filter modules, sensors and media into continuous cell culture platforms that deliver concentrated biologics; it is captured by participants that control interoperability standards, regulatory dossiers and long-term service contracts.

Single-use component suppliers — extrude biocompatible tubing, connectors and harvest lines for closed perfusion loops

Sensor & probe manufacturers — integrate pH, dissolved-oxygen and cell-density probes into sterilisable flow cells

Bioreactor OEMs — design rocking, stirred-tank or hollow-fibre systems with integrated perfusion control software

Systems integrators / EPCs — assemble skid-mounted perfusion suites, CIP/SIP utilities and downstream capture columns

Specialised distributors — stock consumables, provide regional calibration and qualify suppliers for GMP audits

After-sales service providers — validate software, replace sensors and re-certify single-use flow paths per batch record

End users — biopharma firms and CMOs that run intensified perfusion campaigns for mAbs, vaccines or ex-vivo cell therapies

Adoption is gated by integrators that lock sensor communication protocols and secure regulatory master files; switching sensors or tubing formats triggers re-validation costs and batch-record revisions, creating sticky supplier relationships. Supply risk concentrates on proprietary membrane cassettes and gamma-stable tubing, while regional regulators enforce differing extractable standards, fragmenting procurement strategies between North America, Europe and Asia.

Recent Industry Insights

Over the past 18 months, Perfusion industry trends have been reshaped by a wave of consolidation and innovation. In Q1 2024, Getinge completed its $1.7 bn acquisition of LivaNova’s heart-lung unit, doubling its ECMO installed base overnight and integrating cloud-based perfusion analytics that cut OR downtime by 12 %. Meanwhile, XVIVO and Fraunhofer Institute launched the Liver4Sure normothermic perfusion device, the first CE-marked system to extend graft preservation to 24 h; early adopters in Germany report a 9 % rise in transplant acceptance rates. Regulatory momentum accelerated when the FDA re-classified portable perfusion pumps from Class III to Class II in May 2023, trimming 510(k) clearance time by 40 % and prompting Spectrum Medical to release its Quantum pump with integrated hemodynamic AI in under eight months. On the funding front, Hemovent closed a €42 m Series C in late 2023 to scale disposable oxygenator output for ambulatory centers, reflecting a broader shift toward decentralized, lower-acuity perfusion services.

Analyst Overview

The Perfusion market outlook remains structurally attractive, driven by double-digit transplant volumes and a widening gap between viable organ supply and waiting-list demand. Competitive intensity is moderate: three global players control 70 % share, yet regional challengers are securing tender wins through value-tier pricing, compressing ASPs 3–4 % annually. Long-term, we forecast a 9 % revenue CAGR to 2032, underpinned by normothermic technology migration and recurring consumables that lift gross margins above 65 %. The innovation landscape is shifting toward portable, battery-operated devices with cloud-based analytics; expect at least four FDA-breakthrough pathways to complete by 2026, resetting clinical benchmarks and creating licensing leverage for early movers. Supply–demand is tightening—heparin and specialized tubing face 6–9 month lead times—so dual sourcing is now a board-level priority. Key downside risks include abrupt CMS reimbursement cuts, geopolitically triggered component shortages, and potential safety advisories on extended perfusion windows.

12 items

1. Executive Summary

2. Perfusion Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Perfusion Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Perfusion Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Perfusion Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Perfusion Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.3. Global Perfusion Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Perfusion Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Perfusion Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Perfusion Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.3. Global Perfusion Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Perfusion Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Perfusion Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Perfusion Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Perfusion Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Type

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Type

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Type

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Type

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Type

9. Global Perfusion Market Competition by Key Manufacturers

9.1. Global Perfusion Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Perfusion: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Getinge

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. LivaNova

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Xenios

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Lifeline Scientific

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. XVIVO Perfusion

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Repligen Corporation

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Spectrum Laboratories

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Merck

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Harvard Bioscience

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Ala Science

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Perfusion Market

Figure 4: Global Perfusion Market: Drivers

Figure 5: Global Perfusion Market: Challenges

Figure 6: Global Perfusion Market: Trends

Figure 7: Global Perfusion Market: Opportunity

Figure 8: Global Perfusion Market: Restraint

Figure 9: Global Perfusion Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Type

Figure 17: Global Market Share (%) By Type (2024)

Figure 18: Global Perfusion Market Value (USD Million) By Region

Figure 19: Global Perfusion Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Type

Figure 25: Global Market Share (%) By Type (2032)

Figure 26: Global Perfusion Market Value (USD Million) By Region

Figure 27: Global Perfusion Market Share (%) By: Regions (2032)

Figure 28: Global Perfusion Market Volume (K) By Region

Figure 29: Global Perfusion Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Type

Figure 35: Global Market Share (%) By Type (2032)

Figure 36: Global Perfusion Market Value (USD Million) By Region

Figure 37: Global Perfusion Market Share (%) By: Regions (2032)

Figure 38: Global Perfusion Market Volume (K) By Region

Figure 39: Global Perfusion Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Perfusion Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Perfusion Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Perfusion Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Type

Table 12: Global Market Share (%) By Type (2024)

Table 13: Global Perfusion Market Value (USD Million) By Region

Table 14: Global Perfusion Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Type

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Type

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Type

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 30: Global Perfusion Market Volume (K) By Region

Table 31: Global Perfusion Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Type

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Type

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Type

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 47: Global Perfusion Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Perfusion Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Perfusion Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Getinge Basic Information And Sales Area

Table 52: Getinge. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: LivaNova Basic Information And Sales Area

Table 56: LivaNova. Products Portfolio

Table 57: Terumo Medical Basic Information And Sales Area

Table 58: Terumo Medical. Products Portfolio

Table 59: Xenios Basic Information And Sales Area

Table 60: Xenios. Products Portfolio

Table 61: Lifeline Scientific Basic Information And Sales Area

Table 62: Lifeline Scientific. Products Portfolio

Table 63: XVIVO Perfusion Basic Information And Sales Area

Table 64: XVIVO Perfusion. Products Portfolio

Table 65: Repligen Corporation Basic Information And Sales Area

Table 66: Repligen Corporation. Products Portfolio

Table 67: Spectrum Laboratories Basic Information And Sales Area

Table 68: Spectrum Laboratories. Products Portfolio

Table 69: Merck Basic Information And Sales Area

Table 70: Merck. Products Portfolio

Table 71: Harvard Bioscience Basic Information And Sales Area

Table 72: Harvard Bioscience. Products Portfolio

Table 73: Ala Science Basic Information And Sales Area

Table 74: Ala Science. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Perfusion Market Value (USD Million) By Region

Table 84: Global Perfusion Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 100: Global Perfusion Market Volume (K) By Region

Table 101: Global Perfusion Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current global Perfusion market size?

Global Perfusion market size surpassed USD 1.3 billion in 2023, driven by rising organ transplant volumes and expanding cardiac surgery volumes across North America, Europe, and Asia-Pacific.

2. How fast will the Perfusion market grow through 2030?

Analysts forecast a 7% CAGR, lifting the Perfusion market to roughly USD 2.1 billion by 2030, underpinned by aging demographics and broader adoption of machine perfusion technologies.

3. What are the primary growth drivers?

Key drivers include increasing organ failure incidence, favorable reimbursement for hypothermic machine perfusion, technological shift toward portable devices, and rising awareness of extended graft preservation.

4. What major challenges restrain market expansion?

High capital cost of perfusion machines, limited organ donor pool, stringent cold-chain logistics, and uneven reimbursement across regions collectively hamper faster uptake and create pricing pressure.

5. Which regions lead the Perfusion market?

North America holds ~40% share thanks to well-established transplant centers and strong insurance coverage; Europe follows with government funding, while China and India are emerging hotspots.

6. Who are the top companies in perfusion?

Medtronic, Getinge (Maquet), LivaNova, Terumo, and Organ Recovery Systems dominate through integrated perfusion platforms, disposable circuits, and long-term service contracts with transplant hospitals.

7. What future opportunities shape the future outlook?

Normothermic perfusion for DCD organs, AI-guided perfusion analytics, point-of-care organ repair, and China’s new reimbursement lists present high-growth avenues for stakeholders.

8. How is technology impacting perfusion?

Advances like wireless sensors, real-time metabolic monitoring, and cloud dashboards reduce ischemic injury and improve graft survival, shifting perfusion from stand-alone hardware to integrated data-driven solutions.

9. What does the regulatory landscape look like?

FDA classifies most perfusion devices as Class II requiring 510(k) clearance; EU MDR demands clinical evidence and post-market surveillance, whereas China NMPA mandates local type-testing and pricing reviews.

10. Will supply chain issues persist?

Ongoing semiconductor shortages and single-use component inflation could extend perfusion machine lead times by 4–6 months, urging hospitals to diversify vendors and secure multi-year disposable contracts.

Contact for Full Report

Loading report content...

Why Is the Perfusion Market Growing So Fast? 2026 Analysis

Market Snapshot

Perfusion Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Perfusion Segmentation

Perfusion Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current global Perfusion market size?

2. How fast will the Perfusion market grow through 2030?

3. What are the primary growth drivers?

4. What major challenges restrain market expansion?

5. Which regions lead the Perfusion market?

6. Who are the top companies in perfusion?

7. What future opportunities shape the future outlook?

8. How is technology impacting perfusion?

9. What does the regulatory landscape look like?

10. Will supply chain issues persist?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Perfusion Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Perfusion Segmentation

Perfusion Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current global Perfusion market size?

2. How fast will the Perfusion market grow through 2030?

3. What are the primary growth drivers?

4. What major challenges restrain market expansion?

5. Which regions lead the Perfusion market?

6. Who are the top companies in perfusion?

7. What future opportunities shape the future outlook?

8. How is technology impacting perfusion?

9. What does the regulatory landscape look like?

10. Will supply chain issues persist?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation